Skip to main content
Back to campaigns
ico

Long-acting Drug Delivery Formulation Platforms and Technologies

Sep 29, 2025 Nov 10, 2025
Campaign closed

A mid-sized, global pharmaceutical company is seeking novel formulation approaches and technologies that enable drug delivery for sustained periods. Specifically, the team is interested in approaches that allow for once weekly dosing from oral and transdermal delivered drugs, and long-acting injectable platforms (intravenous, intramuscular, and subcutaneous) that allow for a 4–6-month dosing regimen. 

Approaches of Interest: 

  • Approaches should work with small molecule drug compounds 
  • Open to a wide range of formulation and drug delivery approaches for the delivery routes of interest, including, but not limited to, nanoparticles, gastro-retentive gels, transdermal patches, and implants 
  • Solutions that include information on ease of manufacture, regulatory requirements, and safety data will be prioritized 
  • Approaches that have been developed for specific indications are in scope if the platform can be applied to multiple disease areas and drug compounds 

Out of Scope: 

  • Approaches that cannot be applied to small molecules 
  • Active drug delivery devices, such as pumps 

Developmental Stages of Interest: 

  • Opportunities from preclinical stage onwards that have pharmacokinetic validation with a model compound are in scope 
  • Opportunities with in vivo data will be given priority 

Submission Information 

Submission of one-page, 200–300-word briefs is encouraged, along with any optional supplementary information e.g. relevant publications. In submitting to this campaign, you confirm that your submission contains only non-confidential information. 

Opportunity for Collaboration 

Our client is open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case-by-case basis. Appropriate solutions will lead to a funded research and/or manufacturing collaboration of 1-2 years, with potential outcomes leading to licensing of assets, and investment. For earlier stage projects, research funding or PhD studentships may be available. 

Access full details

See the full details and submit your response through Inpart Connect.

View in Connect
Create a free account
Campaign closed on Nov 10, 2025

You can still:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile
Create a free account

Submissions

Eligible submissions are limited to the following list of opportunity types:

Technology
Biopharma assets
Academic profiles
Centers of excellence
Company profiles
Research projects

Top tips for writing submissions for Connect Campaigns

We're always striving to improve our introduction rates so that we can start more conversations across industry and academia, in turn helping biotech companies, universities, startups and research organisations to secure more support and funding for their research.

Read more

Powered by

Inpart Connect
Connecting decision makers

Find out more about launching a campaign to match your company's requirements, get in touch with our team!

Run a campaign